Last updated: January 3, 2024
Sponsor: Vivent Health
Overall Status: Active - Recruiting
Phase
4
Condition
N/ATreatment
Descovy
Clinical Study ID
NCT05528653
IN-US-412-6419
Ages > 18 Male Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- HIV negative on any FDA approved HIV test within 10 days of starting PrEP 18 years andolder
- No medical or mental health comorbidity that would preclude participating in aclinical study as deemed by the study investigator
- Able to understand and sign consent in English or with other language interpreter
- Able to stay in the state catchment area of the license health care provider
- No use of PrEP for more than 30 days in the last year
Exclusion
Exclusion Criteria:
- HIV positive
- If greater and equal to 50 years of age and Renal Glomerular Filtration Rate (GFR) <30mg/g
- <18 years of age
- No access to Internet or devise for telehealth
- Cis-gender Women
Study Design
Total Participants: 150
Treatment Group(s): 1
Primary Treatment: Descovy
Phase: 4
Study Start date:
July 19, 2022
Estimated Completion Date:
July 31, 2024
Study Description
Connect with a study center
Vivent Health
Denver, Colorado 80245
United StatesSite Not Available
Vivent Health
Saint Louis, Missouri 63103
United StatesActive - Recruiting
Viventh Health
Milwaukee, Wisconsin 53203
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.